Works by Oostendorp, Jaap

Results: 14
    1

    HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

    Published in:
    Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-88
    By:
    • van Poelgeest, Mariette I. E.;
    • Welters, Marij J. P.;
    • van Esch, Edith M. G.;
    • Stynenbosch, Linda F. M.;
    • Kerpershoek, Gijs;
    • van Persijn van Meerten, Els L.;
    • den Hende, Muriel van;
    • Löwik, Margriet J. G.;
    • Berends-van der Meer, Dorien M. A.;
    • Fathers, Lorraine M.;
    • Valentijn, A. Rob P. M.;
    • Oostendorp, Jaap;
    • Fleuren, Gert Jan;
    • Melief, Cornelis J. M.;
    • Kenter, Gemma G.;
    • van der Burg, Sjoerd H.
    Publication type:
    Article
    2

    HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial.

    Published in:
    2013
    By:
    • van Poelgeest, Mariette I E;
    • Welters, Marij J P;
    • van Esch, Edith M G;
    • Stynenbosch, Linda F M;
    • Kerpershoek, Gijs;
    • van Persijn van Meerten, Els L;
    • van den Hende, Muriel;
    • Löwik, Margriet J G;
    • Berends-van der Meer, Dorien M A;
    • Fathers, Lorraine M;
    • Valentijn, A Rob P M;
    • Oostendorp, Jaap;
    • Fleuren, Gert Jan;
    • Melief, Cornelis J M;
    • Kenter, Gemma G;
    • van der Burg, Sjoerd H
    Publication type:
    journal article
    3
    4

    The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study.

    Published in:
    Cancer Immunology, Immunotherapy, 2014, v. 63, n. 2, p. 147, doi. 10.1007/s00262-013-1499-2
    By:
    • Vos van Steenwijk, Peggy;
    • Poelgeest, Mariette;
    • Ramwadhdoebe, Tamara;
    • Löwik, Margriet;
    • Berends-van der Meer, Dorien;
    • Minne, Caroline;
    • Loof, Nikki;
    • Stynenbosch, Linda;
    • Fathers, Lorraine;
    • Valentijn, A.;
    • Oostendorp, Jaap;
    • Osse, Elisabeth;
    • Fleuren, Gert;
    • Nooij, Linda;
    • Kagie, Marjolein;
    • Hellebrekers, Bart;
    • Melief, Cornelis;
    • Welters, Marij;
    • Burg, Sjoerd;
    • Kenter, Gemma
    Publication type:
    Article
    5
    6

    A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.

    Published in:
    Cancer Immunology, Immunotherapy, 2012, v. 61, n. 9, p. 1485, doi. 10.1007/s00262-012-1292-7
    By:
    • Vos van Steenwijk, Peggy;
    • Ramwadhdoebe, Tamara;
    • Löwik, Margriet;
    • Minne, Caroline;
    • Berends-van der Meer, Dorien;
    • Fathers, Lorraine;
    • Valentijn, A.;
    • Oostendorp, Jaap;
    • Fleuren, Gert;
    • Hellebrekers, Bart;
    • Welters, Marij;
    • Poelgeest, Mariette;
    • Melief, Cornelis;
    • Kenter, Gemma;
    • Burg, Sjoerd
    Publication type:
    Article
    7
    8
    9
    10

    Addition of interferon-α to the p53-SLP® vaccine results in increased production of interferon-γ in vaccinated colorectal cancer patients: A phase I/II clinical trial.

    Published in:
    International Journal of Cancer, 2013, v. 132, n. 7, p. 1581, doi. 10.1002/ijc.27819
    By:
    • Zeestraten, Eliane C.M.;
    • Speetjens, Frank M.;
    • Welters, Marij J.P.;
    • Saadatmand, Sepideh;
    • Stynenbosch, Linda F.M.;
    • Jongen, Rogier;
    • Kapiteijn, Ellen;
    • Gelderblom, Hans;
    • Nijman, Hans W.;
    • Valentijn, A. Rob P.M.;
    • Oostendorp, Jaap;
    • Fathers, Lorraine M.;
    • Drijfhout, Jan W.;
    • van de Velde, Cornelis J.H.;
    • Kuppen, Peter J.K.;
    • van der Burg, Sjoerd H.;
    • Melief, Cornelis J.M.
    Publication type:
    Article
    11

    Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study.

    Published in:
    International Journal of Cancer, 2012, v. 131, n. 5, p. E670, doi. 10.1002/ijc.27388
    By:
    • Vermeij, Renee;
    • Leffers, Ninke;
    • Hoogeboom, Baukje-Nynke;
    • Hamming, Ineke L.E.;
    • Wolf, Rinze;
    • Reyners, Anna K.L.;
    • Molmans, Barbara H.W.;
    • Hollema, Harry;
    • Bart, Joost;
    • Drijfhout, Jan W.;
    • Oostendorp, Jaap;
    • van der Zee, Ate G.J.;
    • Melief, Cornelis J.;
    • van der Burg, Sjoerd H.;
    • Daemen, Toos;
    • Nijman, Hans W.
    Publication type:
    Article
    12

    Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.

    Published in:
    International Journal of Cancer, 2009, v. 125, n. 9, p. 2104, doi. 10.1002/ijc.24597
    By:
    • Leffers, Ninke;
    • Lambeck, Annechien J.A.;
    • Gooden, Marloes J.M.;
    • Hoogeboom, Baukje-Nynke;
    • Wolf, Rinze;
    • Hamming, Ineke E.;
    • Hepkema, Bouke G.;
    • Willemse, Pax H.B.;
    • Molmans, Barbara H.W.;
    • Hollema, Harry;
    • Drijfhout, Jan W.;
    • Sluiter, Willem J.;
    • Valentijn, A. Rob P.M.;
    • Fathers, Loraine M.;
    • Oostendorp, Jaap;
    • van der Zee, Ate G.J.;
    • Melief, Cornelis J.;
    • van der Burg, Sjoerd H.;
    • Daemen, Toos;
    • Nijman, Hans W.
    Publication type:
    Article
    13

    Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.

    Published in:
    European Journal of Immunology, 2013, v. 43, n. 10, p. 2554, doi. 10.1002/eji.201343324
    By:
    • Rosalia, Rodney A.;
    • Quakkelaar, Esther D.;
    • Redeker, Anke;
    • Khan, Selina;
    • Camps, Marcel;
    • Drijfhout, Jan W.;
    • Silva, Ana Luisa;
    • Jiskoot, Wim;
    • Hall, Thorbald;
    • Veelen, Peter A.;
    • Janssen, George;
    • Franken, Kees;
    • Cruz, Luis J.;
    • Tromp, Angelino;
    • Oostendorp, Jaap;
    • Burg, Sjoerd H.;
    • Ossendorp, Ferry;
    • Melief, Cornelis J. M.
    Publication type:
    Article
    14

    Evaluation of Immunological Cross-Reactivity between Clade A9 High-Risk Human Papillomavirus Types on the Basis of E6-Specific CD4+ Memory T Cell Responses.

    Published in:
    Journal of Infectious Diseases, 2010, v. 202, n. 8, p. 1200, doi. 10.1086/656367
    By:
    • van den Hende, Muriel;
    • Redeker, Anke;
    • Kwappenberg, Kitty M. C.;
    • Franken, Kees L. M. C.;
    • Drijfhout, Jan W.;
    • Oostendorp, Jaap;
    • Valentijn, A. Rob P. M.;
    • Fathers, Loraine M.;
    • Welters, Marij J. P.;
    • Melief, Cornelis J. M.;
    • Kenter, Gemma G.;
    • van der Burg, Sjoerd H.;
    • Offringa, Rienk
    Publication type:
    Article